Table of Contents Author Guidelines Submit a Manuscript
Enzyme Research
Volume 2016, Article ID 2682680, 9 pages
http://dx.doi.org/10.1155/2016/2682680
Review Article

Immunomodulatory Effects of Chitotriosidase Enzyme

1Department of Pediatric Nephrology & Growth and Regeneration, University Hospitals Leuven, KU Leuven, UZ Herestraat 49, P.O. Box 817, 3000 Leuven, Belgium
2Department of Clinical and Chemical Pathology, Inherited Metabolic Disease Laboratory, Center of Social and Preventive Medicine, Faculty of Medicine, Cairo University, 2 Ali Pasha Ibrahim Street, Room 409, Monira, P.O. Box 11628, Cairo, Egypt
3Department of Pediatric Nephrology, Radboud University Medical Center, Post 804, Postbus 9101, 6500 HB Nijmegen, Netherlands

Received 30 September 2015; Accepted 16 December 2015

Academic Editor: Qi-Zhuang Ye

Copyright © 2016 Mohamed A. Elmonem et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. E. M. Hollak, S. van Weely, M. H. J. van Oers, and J. M. F. G. Aerts, “Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease,” The Journal of Clinical Investigation, vol. 93, no. 3, pp. 1288–1292, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. R. N. Tharanathan and F. S. Kittur, “Chitin—the undisputed biomolecule of great potential,” Critical Reviews in Food Science and Nutrition, vol. 43, no. 1, pp. 61–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. G. Boot, E. F. C. Blommaart, E. Swart et al., “Identification of a novel acidic mammalian chitinase distinct from chitotriosidase,” The Journal of Biological Chemistry, vol. 276, no. 9, pp. 6770–6778, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. A. P. Bussink, D. Speijer, J. M. F. G. Aerts, and R. G. Boot, “Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases,” Genetics, vol. 177, no. 2, pp. 959–970, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. G. Boot, G. H. Renkema, A. Strijland, A. J. Van Zonneveld, and J. M. F. G. Aerts, “Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages,” The Journal of Biological Chemistry, vol. 270, no. 44, pp. 26252–26256, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Seibold, S. Donnelly, M. Solon et al., “Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit,” Journal of Allergy and Clinical Immunology, vol. 122, no. 5, pp. 944–950, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Malaguarnera, M. Di Rosa, A. M. Zambito, N. dell'Ombra, F. Nicoletti, and M. Malaguarnera, “Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease,” Gut, vol. 55, no. 9, pp. 1313–1320, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. R. G. Boot, T. A. E. van Achterberg, B. E. van Aken et al., “Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 3, pp. 687–694, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Di Rosa, D. Tibullo, M. Vecchio et al., “Determination of chitinases family during osteoclastogenesis,” Bone, vol. 61, pp. 55–63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Di Rosa, D. Tibullo, D. Cambria et al., “Chitotriosidase expression during monocyte-derived dendritic cells differentiation and maturation,” Inflammation, vol. 38, no. 6, pp. 2082–2091, 2015. View at Publisher · View at Google Scholar
  11. L. Bouzas, J. C. Guinarte, and J. C. Tutor, “Chitotriosidase activity in plasma and mononuclear and polymorphonuclear leukocyte populations,” Journal of Clinical Laboratory Analysis, vol. 17, no. 6, pp. 271–275, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. M. van Eijk, C. P. A. A. van Roomen, G. H. Renkema et al., “Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity,” International Immunology, vol. 17, no. 11, pp. 1505–1512, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Barone, J. Simporé, L. Malaguarnera, S. Pignatelli, and S. Musumeci, “Plasma chitotriosidase activity in acute Plasmodium falciparum malaria,” Clinica Chimica Acta, vol. 331, no. 1-2, pp. 79–85, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. E. H. Choi, P. A. Zimmerman, C. B. Foster et al., “Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India,” Genes and Immunity, vol. 2, no. 5, pp. 248–253, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Vandevenne, V. Campisi, A. Freichels et al., “Comparative functional analysis of the human macrophage chitotriosidase,” Protein Science, vol. 20, no. 8, pp. 1451–1463, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. P. E. Verwer, C. C. Notenboom, K. Eadie et al., “A polymorphism in the chitotriosidase gene associated with risk of mycetoma due to Madurella mycetomatis mycetoma: a retrospective study,” PLOS Neglected Tropical Diseases, vol. 9, no. 9, Article ID e0004061, 2015. View at Publisher · View at Google Scholar
  17. D. L. Wiesner, C. A. Specht, C. K. Lee et al., “Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection,” PLoS Pathogens, vol. 11, no. 3, Article ID e1004701, 2015. View at Publisher · View at Google Scholar
  18. M. Di Rosa, G. Malaguarnera, C. De Gregorio, F. Drago, and L. Malaguarnera, “Evaluation of CHI3L-1 and CHIT-1 expression in differentiated and polarized macrophages,” Inflammation, vol. 36, no. 2, pp. 482–492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. K. W. Kim, J. Park, J. H. Lee et al., “Association of genetic variation in chitotriosidase with atopy in Korean children,” Annals of Allergy, Asthma and Immunology, vol. 110, no. 6, pp. 444–449, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. X.-Q. Pan, “The mechanism of the anticancer function of M1 macrophages and their use in the clinic,” Chinese Journal of Cancer, vol. 31, no. 12, pp. 557–563, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. A. J. James, L. E. Reinius, M. Verhoek et al., “The chitinase proteins YKL-40 and chitotriosidase are increased in both asthma and COPD,” American Journal of Respiratory and Critical Care Medicine, 2015. View at Publisher · View at Google Scholar
  22. M. Di Rosa, K. Mangano, C. De Gregorio, F. Nicoletti, and L. Malaguarnera, “Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease,” Hepatology Research, vol. 43, no. 3, pp. 267–275, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Rosén, C. H. Andersson, U. Andreasson et al., “Increased levels of chitotriosidase and YKL-40 in cerebrospinal fluid from patients with Alzheimer's disease,” Dementia and Geriatric Cognitive Disorders Extra, vol. 4, no. 2, pp. 297–304, 2014. View at Publisher · View at Google Scholar
  24. A. M. Varghese, A. Sharma, P. Mishra et al., “Chitotriosidase—a putative biomarker for sporadic amyotrophic lateral sclerosis,” Clinical Proteomics, vol. 10, no. 1, article 19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. R. G. Boot, G. H. Renkema, M. Verhoek et al., “The human chitotriosidase gene. Nature of inherited enzyme deficiency,” The Journal of Biological Chemistry, vol. 273, no. 40, pp. 25680–25685, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Malaguarnera, J. Simporè, D. A. Prodi et al., “A 24-bp duplication in exon 10 of human chitotriosidase gene from the sub-Saharan to the Mediterranean area: role of parasitic diseases and environmental conditions,” Genes and Immunity, vol. 4, no. 8, pp. 570–574, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Lee, J. Waalen, K. Crain, A. Smargon, and E. Beutler, “Human chitotriosidase polymorphisms G354R and A442V associated with reduced enzyme activity,” Blood Cells, Molecules, and Diseases, vol. 39, no. 3, pp. 353–360, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. K. H. Woo, B. H. Lee, S. H. Heo et al., “Allele frequency of a 24 bp duplication in exon 10 of the CHIT1 gene in the general Korean population and in Korean patients with Gaucher disease,” Journal of Human Genetics, vol. 59, no. 5, pp. 276–279, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Fusetti, H. von Moeller, D. Houston et al., “Structure of human chitotriosidase. Implications for specific inhibitor design and function of mammalian chitinase-like lectins,” Journal of Biological Chemistry, vol. 277, no. 28, pp. 25537–25544, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. K. B. Eide, A. R. Lindbom, V. G. H. Eijsink, A. L. Norberg, and M. Sørlie, “Analysis of productive binding modes in the human chitotriosidase,” FEBS Letters, vol. 587, no. 21, pp. 3508–3513, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. L. W. Stockinger, K. B. Eide, A. I. Dybvik et al., “The effect of the carbohydrate binding module on substrate degradation by the human chitotriosidase,” Biochimica et Biophysica Acta, vol. 1854, no. 10, pp. 1494–1501, 2015. View at Google Scholar
  32. F. Fadel, Y. Zhao, R. Cachau et al., “New insights into the enzymatic mechanism of human chitotriosidase (CHIT1) catalytic domain by atomic resolution X-ray diffraction and hybrid QM/MM,” Acta Crystallographica Section D: Biological Crystallography, vol. 71, no. 7, pp. 1455–1470, 2015. View at Publisher · View at Google Scholar
  33. I. Labadaridis, E. Dimitriou, M. Theodorakis, G. Kafalidis, A. Velegraki, and H. Michelakakis, “Chitotriosidase in neonates with fungal and bacterial infections,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 90, no. 6, pp. F531–F532, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. G. Kurt, T. Cayci, P. Onguru et al., “Serum chitotriosidase enzyme activity in patients with Crimean-Congo hemorrhagic fever,” Clinical Chemistry and Laboratory Medicine, vol. 47, no. 12, pp. 1543–1547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Shibata, L. A. Foster, W. J. Metzger, and Q. N. Myrvik, “Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice,” Infection and Immunity, vol. 65, no. 5, pp. 1734–1741, 1997. View at Google Scholar · View at Scopus
  36. C. L. Bueter, C. A. Specht, and S. M. Levitz, “Innate sensing of chitin and chitosan,” PLoS Pathogens, vol. 9, no. 1, Article ID e1003080, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Shibata, W. J. Metzger, and Q. N. Myrvik, “Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production,” The Journal of Immunology, vol. 159, no. 5, pp. 2462–2467, 1997. View at Google Scholar · View at Scopus
  38. L. Malaguarnera, M. Musumeci, M. Di Rosa, A. Scuto, and S. Musumeci, “Interferon-gamma, tumor necrosis factor-α, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages,” Journal of Clinical Laboratory Analysis, vol. 19, no. 3, pp. 128–132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. O. Sharif, V. N. Bolshakov, S. Raines, P. Newham, and N. D. Perkins, “Transcriptional profiling of the LPS induced NF-κB response in macrophages,” BMC Immunology, vol. 8, article 1, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Schroder, P. J. Hertzog, T. Ravasi, and D. A. Hume, “Interferon-γ: an overview of signals, mechanisms and functions,” Journal of Leukocyte Biology, vol. 75, no. 2, pp. 163–189, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. J. P. Boyle, R. Parkhouse, and T. P. Monie, “Insights into the molecular basis of the NOD2 signalling pathway,” Open Biology, vol. 4, no. 12, Article ID 140178, 2014. View at Publisher · View at Google Scholar
  42. M. van Eijk, S. S. Scheij, C. P. A. A. van Roomen, D. Speijer, R. G. Boot, and J. M. F. G. Aerts, “TLR- and NOD2-dependent regulation of human phagocyte-specific chitotriosidase,” FEBS Letters, vol. 581, no. 28, pp. 5389–5395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Malaguarnera, M. Musumeci, F. Licata, M. Di Rosa, A. Messina, and S. Musumeci, “Prolactin induces chitotriosidase gene expression in human monocyte-derived macrophages,” Immunology Letters, vol. 94, no. 1-2, pp. 57–63, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Di Rosa, A. M. Zambito, A. R. Marsullo, G. Li Volti, and L. Malaguarnera, “Prolactin induces chitotriosidase expression in human macrophages through PTK, PI3-K, and MAPK pathways,” Journal of Cellular Biochemistry, vol. 107, no. 5, pp. 881–889, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Martinon, L. Agostini, E. Meylan, and J. Tschopp, “Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome,” Current Biology, vol. 14, no. 21, pp. 1929–1934, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Prencipe, I. Caiello, S. Cherqui et al., “Inflammasome activation by cystine crystals: implications for the pathogenesis of cystinosis,” Journal of the American Society of Nephrology, vol. 25, no. 6, pp. 1163–1169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Lieb, C. Kaltschmidt, B. Kaltschmidt et al., “Interleukin-1β uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor α genes in the human astrocytoma cell line U373,” Journal of Neurochemistry, vol. 66, no. 4, pp. 1496–1503, 1996. View at Google Scholar · View at Scopus
  48. D. Artis and H. Spits, “The biology of innate lymphoid cells,” Nature, vol. 517, no. 7534, pp. 293–301, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Di Rosa, G. Malaguarnera, C. De Gregorio, F. D'Amico, M. C. Mazzarino, and L. Malaguarnera, “Modulation of chitotriosidase during macrophage differentiation,” Cell Biochemistry and Biophysics, vol. 66, no. 2, pp. 239–247, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. M. A. Elmonem, S. H. Makar, L. van den Heuvel et al., “Clinical utility of chitotriosidase enzyme activity in nephropathic cystinosis,” Orphanet Journal of Rare Diseases, vol. 9, no. 1, article 155, 2014. View at Publisher · View at Google Scholar
  51. J. Correale and M. Fiol, “Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis,” Multiple Sclerosis, vol. 17, no. 5, pp. 521–531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Létuvé, A. Kozhich, A. Humbles et al., “Lung chitinolytic activity and chitotriosidase are elevated in chronic obstructive pulmonary disease and contribute to lung inflammation,” The American Journal of Pathology, vol. 176, no. 2, pp. 638–649, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. C. G. Lee, E. L. Herzog, F. Ahangari et al., “Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-β1 signaling,” Journal of Immunology, vol. 189, no. 5, pp. 2635–2644, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. M. A. Elmonem, H. S. Amin, R. A. El-Essawy et al., “Association of chitotriosidase enzyme activity and genotype with the risk of nephropathy in type 2 diabetes,” Clinical Biochemistry, 2015. View at Publisher · View at Google Scholar
  55. T. E. Sutherland, R. M. Maizels, and J. E. Allen, “Chitinases and chitinase-like proteins: potential therapeutic targets for the treatment of T-helper type 2 allergies,” Clinical and Experimental Allergy, vol. 39, no. 7, pp. 943–955, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Shao, Q. J. Cao, R. B. Arenas, C. Bigelow, B. Bentley, and W. Yan, “Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers,” British Journal of Cancer, vol. 105, no. 8, pp. 1203–1209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. X. W. Wang, C. L. Cai, J. M. Xu, H. Jin, and Z. Y. Xu, “Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis,” Tumor Biology, vol. 36, no. 2, pp. 901–907, 2015. View at Google Scholar
  58. N. Ngernyuang, R. A. Francescone, P. Jearanaikoon et al., “Chitinase 3 like 1 is associated with tumor angiogenesis in cervical cancer,” International Journal of Biochemistry and Cell Biology, vol. 51, no. 1, pp. 45–52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. X. Q. Pan, C. C. Shih, and J. Harday, “Chitinase induces lysis of MCF-7 cells in culture and of human breast cancer xenograft B11-2 in SCID mice,” Anticancer Research, vol. 25, no. 5, pp. 3167–3172, 2005. View at Google Scholar · View at Scopus
  60. B. Bonnotte, N. Larmonier, N. Favre et al., “Identification of tumor-infiltrating macrophages as the killers of tumor cells after immunization in a rat model system,” Journal of Immunology, vol. 167, no. 9, pp. 5077–5083, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. N. N. Sanders, V. G. H. Eijsink, P. S. van den Pangaart et al., “Mucolytic activity of bacterial and human chitinases,” Biochimica et Biophysica Acta—General Subjects, vol. 1770, no. 5, pp. 839–846, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Shemesh, L. Deroma, B. Bembi et al., “Enzyme replacement and substrate reduction therapy for Gaucher disease,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD010324, 2015. View at Google Scholar
  63. M. Harlander, B. Salobir, M. Zupančič, M. Dolenšek, T. Bavčar Vodovnik, and M. Terčelj, “Serial chitotriosidase measurements in sarcoidosis—two to five year follow-up study,” Respiratory Medicine, vol. 108, no. 5, pp. 775–782, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. M. A. Elmonem, D. I. Ramadan, M. S. M. Issac, L. A. Selim, and S. M. Elkateb, “Blood spot versus plasma chitotriosidase: a systematic clinical comparison,” Clinical Biochemistry, vol. 47, no. 1-2, pp. 38–43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Ries, E. Schaefer, T. Lührs et al., “Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A/B and C,” Journal of Inherited Metabolic Disease, vol. 29, no. 5, pp. 647–652, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. A. C. Vedder, J. Cox-Brinkman, C. E. M. Hollak et al., “Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy,” Molecular Genetics and Metabolism, vol. 89, no. 3, pp. 239–244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. E. Dimitriou, M. Cozar, I. Mavridou, D. Grinberg, L. Vilageliu, and H. Michelakakis, “The spectrum of Krabbe disease in Greece: biochemical and molecular findings,” JIMD Reports, 2015. View at Publisher · View at Google Scholar
  68. Ž. Reiner, O. Guardamagna, D. Nair et al., “Lysosomal acid lipase deficiency—an under-recognized cause of dyslipidaemia and liver dysfunction,” Atherosclerosis, vol. 235, no. 1, pp. 21–30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Muranjan, S. Agarwal, K. Lahiri, and M. Bashyam, “Novel biochemical abnormalities and genotype in Farber disease,” Indian Pediatrics, vol. 49, no. 4, pp. 320–322, 2012. View at Google Scholar · View at Scopus
  70. A. Wajner, K. Michelin, M. G. Burin et al., “Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease,” Clinical Biochemistry, vol. 40, no. 5-6, pp. 365–369, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Caciotti, M. Di Rocco, M. Filocamo et al., “Type II sialidosis: review of the clinical spectrum and identification of a new splicing defect with chitotriosidase assessment in two patients,” Journal of Neurology, vol. 256, no. 11, pp. 1911–1915, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Tasci, S. Tapan, S. Ozkaya et al., “Efficacy of serum chitotriosidase activity in early treatment of patients with active tuberculosis and a negative sputum smear,” Therapeutics and Clinical Risk Management, vol. 8, pp. 369–372, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. O. Coskun, S. Oter, H. Yaman, S. Kilic, I. Kurt, and C. P. Eyigun, “Evaluating the validity of serum neopterin and chitotriosidase levels in follow-up brucellosis patients,” Internal Medicine, vol. 49, no. 12, pp. 1111–1118, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Iyer, M. van Eijk, E. Silva et al., “Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy,” Clinical Immunology, vol. 131, no. 3, pp. 501–509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. E. Bargagli, M. Margollicci, A. Luddi et al., “Chitotriosidase activity in patients with interstitial lung diseases,” Respiratory Medicine, vol. 101, no. 10, pp. 2176–2181, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Sonmez, C. Haymana, S. Tapan et al., “Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus,” Endocrine, vol. 37, no. 3, pp. 455–459, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Artieda, A. Cenarro, A. Gañán et al., “Serum chitotriosidase activity is increased in subjects with atherosclerosis disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 9, pp. 1645–1652, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Kologlu, S. K. Ucar, E. Levent, Y. D. Akcay, M. Coker, and E. Y. Sozmen, “Chitotriosidase as a possible marker of clinically evidenced atherosclerosis in dyslipidemic children,” Journal of Pediatric Endocrinology and Metabolism, vol. 27, no. 7-8, pp. 701–708, 2014. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Bustamante, C. Dominguez, V. Rodriguez-Sureda et al., “Prognostic value of plasma chitotriosidase activity in acute stroke patients,” International Journal of Stroke, vol. 9, no. 7, pp. 910–916, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. B. S. Yildiz, B. Barutcuoglu, Y. I. Alihanoglu et al., “Serum chitotriosidase activity in acute coronary syndrome,” Journal of Atherosclerosis and Thrombosis, vol. 20, no. 2, pp. 134–141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. M. R. Safarinejad and S. Safarinejad, “Plasma chitotriosidase activity and arteriogenic erectile dysfunction: association with the presence, severity, and duration,” The Journal of Sexual Medicine, 2010. View at Publisher · View at Google Scholar
  82. V. Pagliardini, S. Pagliardini, L. Corrado et al., “Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study,” Journal of the Neurological Sciences, vol. 348, no. 1-2, pp. 245–250, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. B. Olsson, C. Malmeström, H. Basun et al., “Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials,” Journal of Alzheimer's Disease, vol. 32, no. 2, pp. 273–276, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. P. J. Orchard, T. Lund, W. Miller et al., “Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy,” Journal of Neuroinflammation, vol. 8, article 144, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Aydogdu, I. Tasci, S. Tapan et al., “Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: a pathophysiological link between inflammation and impaired insulin sensitivity?” Experimental and Clinical Endocrinology and Diabetes, vol. 120, no. 5, pp. 261–265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. I. Alanbay, H. Coksuer, C. M. Ercan et al., “Chitotriosidase levels in patients with severe endometriosis,” Gynecological Endocrinology, vol. 28, no. 3, pp. 220–223, 2012. View at Publisher · View at Google Scholar · View at Scopus
  87. Ü. Aksoy, H. Aksoy, G. Açmaz, M. Babayiğit, and Ö. Kandemir, “Umbilical artery serum chitotriosidase concentration in pregnancies complicated by preeclampsia and relationship between chitotriosidase levels and fetal blood flow velocity,” Hypertension in Pregnancy, vol. 32, no. 4, pp. 401–409, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Taylan, O. Gurler, B. Toprak et al., “S1000A12, chitotriosidase, and resolvin D1 as potential biomarkers of familial mediterranean fever,” Journal of Korean Medical Science, vol. 30, no. 9, pp. 1241–1245, 2015. View at Publisher · View at Google Scholar
  89. R. Barone, G. Bertrand, J. Simporè, M. Malaguarnera, and S. Musumeci, “Plasma chitotriosidase activity in β-thalassemia major: a comparative study between Sicilian and Sardinian patients,” Clinica Chimica Acta, vol. 306, no. 1-2, pp. 91–96, 2001. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Acar, M. Keskek, F. K. Işman, M. Kucur, and M. Tez, “Serum chitotriosidase activity in acute appendicitis: preliminary results,” American Journal of Emergency Medicine, vol. 30, no. 5, pp. 775–777, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. J. K. H. Brunner, S. Scholl-Bürgi, D. Hössinger, P. Wondrak, M. Prelog, and L.-B. Zimmerhackl, “Chitotriosidase activity in juvenile idiopathic arthritis,” Rheumatology International, vol. 28, no. 9, pp. 949–950, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Kucur, F. K. Isman, C. Balci et al., “Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia,” Urologic Oncology: Seminars and Original Investigations, vol. 26, no. 1, pp. 47–52, 2008. View at Publisher · View at Google Scholar · View at Scopus